InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: tilator post# 31592

Wednesday, 12/06/2017 4:26:04 PM

Wednesday, December 06, 2017 4:26:04 PM

Post# of 38634
Tilator- Why are you so hot on Effexor XR? There are already 10 generic companies with approval. Effexor XR will wind up with Gluco and Keppra- no partner, no commercialization. The only ones that matter at this point are Pristiq and Lamictal. Those are partnered with MNK and can start adding to the bottom line immediately. My prediction is Generic Effexor XR will eventually receive approval but run into the exact same problems as Gluco and Keppra. Hope I am wrong... But I am just trying to keep my expectation realistic. And if that is the case, there will be bonuses due which strain shareholders further... While not adding anything to the revenue stream.